ClinicalTrials.Veeva

Menu

The French EsoGastricTumours Data Base (FREGAT)

U

University Hospital, Lille

Status

Enrolling

Conditions

Esophageal Disease

Study type

Observational

Funder types

Other

Identifiers

NCT02526095
2013-A01281-44 (Other Identifier)
2013_33

Details and patient eligibility

About

This retrospective study aims at evaluating the outcomes of gastrointestinal stromal tumor after surgery.

Enrollment

15,000 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Patient with

  • esophageal cancer, gastric or gastroesophageal junction diagnosed biopsy , regardless of the subtype of cancer, tumor stage or treatment envisaged.
  • Naive treatment for this cancer,
  • Naive treatment for this cancer , failing that received neoadjuvant treatment ,
  • Male or female ≥ 18 years.
  • social protection scheme .
  • sign a free and informed consent for blood sampling , the different questionnaires and the collection of patient information.

Exclusion Criteria:

Male or female aged ( e) under 18 years.

  • Private person of liberty or under supervision (including guardianship ) .
  • People who do not speak French.
  • Major Nobody unable to consent .
  • Patient FREGAT already included in the base.
  • Patient Refusal .

Trial contacts and locations

31

Loading...

Central trial contact

Guillaume Piessen, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems